LabCorp has introduced a suite of cell and gene therapy development solutions from Covance, its drug development business. These solutions are designed to reduce time and risk for sponsors at each phase and across the full continuum of their therapy development needs in one of the industry’s fastest-growing segments. With more than 20 years of experience in delivering development solutions for advanced therapies, such as cell and gene therapy products, Covance provides a offering of specialized...